SAB Therapeutics announced its first-in-human trial of new immunotherapy approach has shown efficacy in antibiotic-resistant bacteria based on a recent paper published online in Clinical Infectious Diseases.
Merck: Outsmarting Superbugs
Antibiotics, Antimicrobial Stewardship (AMS), Antimicrobials, Business, CDC, Clinical Trials, Data, Healthcare Physicians, Infections, Infectious Disease, Infectious Diseases, Initiative, Microbes, Microbiology, Physicians, Policy, R&D, Superbugs, Superbugs, Surveillance, TrendsMerck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.